Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-10-07

Clinical Trial Update: Melatonin for Delirium Prophylaxis [Phase 4]

View source ↗

Summary

Phase 4 trial of melatonin for delirium prophylaxis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: University of British Columbia | Conditions: Delirium | Phase 4 | Status: WITHDRAWN